about
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with...
Read More
73.43
-0.95
(-1.28%)
5.5M
XNAS Volume
XNAS 27 Feb, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for DexCom is on 02 Mar 2026 for the purpose of 47th Annual Raymond James Institutional Investors Conference
See details
High Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors
View Similar
Embed DVM
DexCom Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..